Literature DB >> 22024233

Primary Ewing's sarcoma affecting the central nervous system: a review and proposed prognostic considerations.

George M Ibrahim1, Aria Fallah, Mehdi Shahideh, Uri Tabori, James T Rutka.   

Abstract

Ewing's sarcoma (ES) is a part of a larger family of round blue cell tumors, which occasionally manifest as osseous or extraosseous lesions adjacent to or within the central nervous system (CNS). While a large body of literature exists on ES of bone, data are lacking on tumors with cranial or spinal components that affect the CNS. Here, we perform a systematic review of the literature and summarize the best available evidence on diagnosis, treatment and outcomes of ES affecting the CNS with emphasis on the breadth of clinical presentations, diagnostic tools and emerging management options for these rare and challenging lesions. We include a review of known prognostic factors and propose several new considerations for prognostication of ES affecting the CNS.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22024233     DOI: 10.1016/j.jocn.2011.06.001

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  11 in total

1.  [Shoulder girdle, AC and SC joints].

Authors:  A B Imhoff
Journal:  Oper Orthop Traumatol       Date:  2014-06       Impact factor: 1.154

2.  Primary Ewing sarcoma of the cavernous sinus.

Authors:  Gaurav Srivastava; George I Jallo; Neil R Miller
Journal:  Childs Nerv Syst       Date:  2015-05-09       Impact factor: 1.475

3.  Multifocal primary central nervous system Ewing sarcoma presenting with intracranial hemorrhage and leptomeningeal dissemination: illustrative case.

Authors:  Anna L Huguenard; Yuping Derek Li; Nima Sharifai; Stephanie M Perkins; Sonika Dahiya; Michael R Chicoine
Journal:  J Neurosurg Case Lessons       Date:  2021-03-08

4.  Ewing Sarcoma With Emphasis on Extra-skeletal Ewing Sarcoma: A Decade's Experience From a Single Centre in India.

Authors:  Sudha S Murthy; S Challa; Kvvn Raju; S J Rajappa; D Fonseca; S D Gundimeda; B V Rao; F Ahmed; S Kodandapani; L Nambaru; M C Mundada; R Sharma; K M Mallavarapu; V C Koppula; T S Rao
Journal:  Clin Pathol       Date:  2020-11-11

5.  Primary intracranial Ewing's sarcoma with unusual features.

Authors:  Katherine A VandenHeuvel; Rami N Al-Rohil; Michael E Stevenson; Jiang Qian; Naina L Gross; Rene McNall-Knapp; Shibo Li; Eric P Wartchow; Gary W Mierau; Kar-Ming Fung
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

6.  What's in a name? Intracranial peripheral primitive neuroectodermal tumors and CNS primitive neuroectodermal tumors are not the same.

Authors:  K Müller; B Diez; A Muggeri; T Pietsch; C Friedrich; S Rutkowski; K von Hoff; A O von Bueren; I Zwiener; F Bruns
Journal:  Strahlenther Onkol       Date:  2013-03-23       Impact factor: 3.621

7.  Dural metastasis of Ewing's sarcoma.

Authors:  Atef Ben Nsir; Mohamed Boughamoura; Mezri Maatouk; Mohamed Kilani; Nejib Hattab
Journal:  Surg Neurol Int       Date:  2013-07-23

Review 8.  Primary and Metastatic Intracranial Ewing Sarcoma at Diagnosis: Retrospective International Study and Systematic Review.

Authors:  Lianne M Haveman; Andreas Ranft; Henk van den Berg; Stephanie Klco-Brosius; Ruth Ladenstein; Michael Paulussen; Heribert Juergens; Uta Dirksen; Johannes H M Merks
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

9.  Cranial Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumors: A Retrospective Study Focused on Prognostic Factors and Long-Term Outcomes.

Authors:  Jun Chen; Ruimin Cheng; Fanfan Fan; Yifeng Zheng; Yakun Li; Yong Chen; Yu Wang
Journal:  Front Oncol       Date:  2019-10-09       Impact factor: 6.244

10.  Ewing's Sarcoma as a Second Malignancy in Long-Term Survivors of Childhood Hematologic Malignancies.

Authors:  Fabian Wolpert; Michael A Grotzer; Felix Niggli; Dieter Zimmermann; Elisabeth Rushing; Beata Bode-Lesniewska
Journal:  Sarcoma       Date:  2016-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.